Research leads to promising combination therapy for type 1 diabetes
Evidence review examines both benefits and harms for lung cancer screening
9 March 2021Unconscious biases can drive foodborne illness outbreaks, researchers find
9 March 2021Research leads to promising combination therapy for type 1 diabetes
Translational research led by scientists at La Jolla Institute for Immunology (LJI) has resulted in a promising combination therapeutic candidate for adults with recent-onset type 1 diabetes.
